Characteristics and outcomes of patients with or without a bleeding event: results from the triple antiplatelets for reducing dependency in ischaemic stroke (TARDIS) trial

QR Code

Characteristics and outcomes of patients with or without a bleeding event: results from the triple antiplatelets for reducing dependency in ischaemic stroke (TARDIS) trial

Background: Several studies showed that hyperglycaemia is associated with poorer prognosis in intracerebral haemorrhage. We explored the characteristics and outcomes of patients with hyperglycaemia in the Tranexamic acid in IntraCerebral Haemorrhage-2 (TICH-2) trial. Methods: Of the 2325 patients r...

Full description

Bibliographic Details
Main Authors:	Woodhouse, Lisa J., Flaherty, Katie, Appleton, Jason P., Sprigg, Nikola, Bath, Philip M.W.
Format:	Conference or Workshop Item
Published:	2018
Online Access:	https://eprints.nottingham.ac.uk/50770/

Similar Items

Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
by: Bath, Philip M.W., et al.
Published: (2015)

Prediction of major bleeding with a S2TOP-BLEED score in acute ischaemic stroke or TIA patients: a sub-study of the TARDIS trial
by: Woodhouse, Lisa J., et al.
Published: (2018)

Impact of atrial fibrillation diagnosis or carotid enderterectomy requirement on outcome in patients from the triple antiplatelets for reducing dependency after ischaemic stroke (TARDIS) trial
by: Woodhouse, Lisa J., et al.
Published: (2018)

Baseline characteristics of the 3,096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial
by: Bath, Philip M.W., et al.
Published: (2017)

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
by: Beridze, M., et al.
Published: (2015)

Baseline predictors of on-treatment platelet activity (as P-selectin expression) in patients in the triple aniplatelets for reducing dependency in ischaemic stroke (TARDIS) trial
by: Bath, Philip M., et al.
Published: (2018)

Antiplatelet therapy following ischaemic stroke: continue or change pre-existing therapy?
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)

Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets
by: Hilkens, Nina A., et al.
Published: (2017)

Serum amyloid protein is associated with outcome following acute ischaemic stroke: data from the REmote ischaemic Conditioning After Stroke Trial (RECAST)
by: Appleton, Jason P., et al.
Published: (2018)

Peripheral and central haemodynamics in patients on isosorbide mononitrate and/or cilostazol with lacunar ischaemic stroke: data from the LACI-1 trial
by: Appleton, Jason P., et al.
Published: (2018)

Remote assessment of platelet function in patients with acute stroke or transient ischaemic attack
by: Bath, Philip M.W., et al.
Published: (2017)

A randomised controlled trial of triple antiplatelet therapy (Aspirin, Clopidogrel and Dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
by: Sprigg, Nikola, et al.
Published: (2008)

Platelet and haemoglobin levels in patients on isosorbide mononitrate and/or cilostazol with lacunar ischaemic stroke: data from the LACI-1 trial
by: Appleton, Jason P., et al.
Published: (2018)

Blood pressure management in acute stroke
by: Appleton, Jason P., et al.
Published: (2016)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
by: Hilkens, Nina A., et al.
Published: (2018)

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
by: Bath, Philip M.W., et al.
Published: (2018)

Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)

Therapeutic potential of transdermal glyceryl trinitrate in the management of acute stroke
by: Appleton, Jason P., et al.
Published: (2016)

The Insulin Resistance Intervention after Stroke trial: a perspective on future practice and research
by: Bath, Philip M.W., et al.
Published: (2016)

Speeding stroke recovery? A systematic review of amphetamine after stroke
by: Sprigg, Nikola, et al.
Published: (2009)

Remote Ischaemic Conditioning after Stroke Trial (RECAST): a pilot randomised placebo controlled phase II trial in acute ischaemic stroke (ISRCTN 86672015)
by: England, Timothy J., et al.
Published: (2017)

Blood pressure in acute stroke: to treat or not to treat - that is still the question
by: Bath, Philip M.W., et al.
Published: (2018)

Antiplatelet therapy for secondary prevention in patients with ischaemic stroke and transient ischaemic attack: a retrospective cohort study in Malaysia
by: Ab Rahman N,, et al.
Published: (2023)

Antiplatelet activity should be measured routinely: no
by: Bath, Philip M.W.
Published: (2009)

Control of blood pressure after stroke
by: Bath, Philip M.W., et al.
Published: (2006)

Guidelines for management of ischaemic stroke and transient ischaemic attack 2008
by: Ringleb, Peter A., et al.
Published: (2008)

Sex differences in quality of life in stroke survivors. Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
by: Gray, Laura J., et al.
Published: (2007)

Impact of ultra/hyper-acute administration of glyceryl trinitrate on secondary outcome after acute stroke: a meta-analysis of individual patient data from randomised trials
by: Bath, Philip M., et al.
Published: (2018)

Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST)
by: Gray, Laura J., et al.
Published: (2006)

The effect of transdermal glyceryl trinitrate on imaging characteristics in acute ischaemic stroke: data from the Efficacy of Nitric Oxide in Stroke trial
by: Appleton, Jason P.
Published: (2018)

Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
by: Sprigg, Nikola, et al.
Published: (2007)

Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333)
by: Sprigg, Nikola, et al.
Published: (2007)

Statistical analysis plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial
by: Bath, Philip M.W., et al.
Published: (2014)

Compression stockings and the prevention of symptomatic venous thromboembolism: data from the Tinzaparin in Acute Ischaemic Stroke Trial
by: Sprigg, Nikola, et al.
Published: (2005)

The effect of transdermal glyceryl trinitrate in acute stroke patients with carotid stenosis: data from the Efficacy of Nitric Oxide in Stroke trial
by: Appleton, J.P., et al.
Published: (2018)

A European, multicentre, phase III, clinical trial of hypothermia for acute ischaemic stroke: EuroHYP-1
by: Sprigg, Nikola, et al.
Published: (2018)

Statistical analysis plan for the ‘Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2)’
by: Scutt, Polly, et al.
Published: (2018)

Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the 'Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)
by: Sprigg, Nikola, et al.
Published: (2007)

Hypercholesterolaemia and vascular dementia
by: Appleton, Jason P., et al.
Published: (2017)

Compression stockings and the prevention of symptomatic venous thromboembolism: data from the Tinzaparin in Acute Ischaemic Stroke Trial
by: Sprigg, Nikola, et al.
Published: (2005)